The Vertical Group

BioSET is developing synthetic growth factors for medical devices, with successful clinical trials in Canada and FDA-approved trials in the US.

#Medical Technology

Galil Medical specializes in cryotherapy systems for cancer treatment, with a direct sales organization in the US and worldwide sales exceeding $20 million.

#Medical Technology

Incumed partners with inventors to develop new medical products that may not attract large corporations or venture capital.

#Medical Device Incubator

InPhenix develops optoelectronic devices for medical, defense, and telecom markets, and is cash flow positive.

#Optoelectronic Devices

Monteris Medical provides MRI-guided neurosurgical ablation tools for treating brain lesions and tumors.

#Neurosurgical Technology

Meritage Pharma develops prescription products for gastrointestinal and atopic diseases, with a focus on eosinophilic esophagitis.

#Pharmaceuticals

Omada Health builds digital health programs for chronic disease prevention, with a flagship product based on the Diabetes Prevention Program.

#Digital Health

Oncomed develops drugs targeting cancer stem cells, with strategic alliances with GSK and Bayer Pharmaceuticals.

#Biopharmaceuticals

Outset Medical focuses on dialysis technology, with the Tablo system designed for ease of use and cost-efficiency.

#Medical Technology

ProteinSimple develops research tools for biotechnology, improving throughput and accuracy of protein detection assays.

#Biotechnology

Remedy Pharmaceuticals develops new drug treatments for stroke victims, using intellectual property from the University of Maryland.

#Healthcare

Silk Road Medical develops endovascular approaches for neurovascular disease treatment, with ongoing clinical trials.

#Medical Technology

SingularBIO is developing a platform for cost-effective, high-precision diagnostic tests in personalized medicine.

#Diagnostics

Tepha develops medical devices using unique biomaterials, with FDA approval for a PHA polymer derived device.

#Medical Devices

TetraLogic develops drugs for cancer treatment, with promising clinical studies and major equity financing.

#Pharmaceuticals

Tornier is a leader in shoulder and extremity joint replacement systems, with annual sales of approximately $200 million.

#Orthopedics

ViaCyte is developing islet cell transplantation technology for diabetes treatment, with strategic partnerships in place.

#Biotechnology